Rajesh Pahwa is a Neurology physician affiliated with University of Kansas Medical Center. OpenAlex indexes 17 publications with 616 citations (h-index 9); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3901 Rainbow Blvd
4070 Delp Mail Stop 4017
Kansas City, KS 661600001
Telephone
913-588-6970Registry record last updated 8 Jul 2007.
Clinical trials
- Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status
Sponsor: Global Kinetics Corporation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- MDD US Operations, LLCProgram year202592 payments$77,697openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202515 payments$16,238openpaymentsdata.cms.gov ↗
- H. Lundbeck A SProgram year20256 payments$10,105openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92.7%Aromatic Amino Acid Decarboxylation Inhibitor32.5%Carbidopa-Levodopa62%Carbidopa-Levodopa Er24%Rytary10%Dhivy2%Crexont2%Carbidopa-Levodopa-Entacapone1%Part D<11 patientsInfluenza A M2 Protein Inhibitor7.3%Amantadine74%Gocovri26%Part D≥130 patients+ 24 more classes in this area
Cardiovascular
3.9%alpha-Adrenergic Agonist1.8%Midodrine Hcl100%Part D≥48 patientsBeta blocker1.2%Propranolol Hcl74%Propranolol Hcl Er26%Part D<11 patients+ 1 more class in this area
Musculoskeletal
1.2%Central alpha-2 Adrenergic Agonist0.7%Tizanidine Hcl100%Part D≥19 patientsgamma-Aminobutyric Acid-ergic Agonist0.4%Baclofen100%Part D≥15 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2002–2013 per NIH RePORTER. The latest:
- Continuation of NET-PD Trials at the University of Kansas Medical Center
University of Kansas Medical Center
FY2013$59,018U10NS044469 - KU Center for Neuroprotection in Parkinson's Disease
University of Kansas Medical Center
FY2012$58,241U10NS044469 - KU Center for Neuroprotection in Parkinson's Disease
University of Kansas Medical Center
FY2011$51,465U10NS044469
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluating Out-of-Pocket Costs for Specialty Medications in Parkinson’s Disease: A Comparative Study of Pimavanserin and Inhaled Levodopa
Parkinsonism & Related Disorders
2025 - Study design and rationale for an international study of DBS for movement disorders
Parkinsonism & Related Disorders
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Gary Gronseth, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”